Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

ecteinascidin

(ek-TIH-nuh-SY-din)
A drug used to treat liposarcoma and leiomyosarcoma (types of soft tissue sarcoma) that cannot be removed by surgery or have spread to other parts of the body. It is used in patients who have already been treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Ecteinascidin may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent. Also called ET 743, trabectedin, and Yondelis.
Search NCI's Dictionary of Cancer Terms